<DOC>
	<DOCNO>NCT00515398</DOCNO>
	<brief_summary>The purpose study see molecule call pharmacological chaperone affect cell patient Pompe disease . The study last 1 2 visit include blood collection , urine collection , two skin biopsy . Information also collect medical record disease history diagnosis . Patients receive study medication .</brief_summary>
	<brief_title>A Study Evaluate Effects Pharmacological Chaperones Cells From Patients With Pompe Disease</brief_title>
	<detailed_description>The study design evaluate response cell line derive blood skin tissue Pompe patient pharmacological chaperone . Samples blood skin tissue obtain make cell line use test pharmacological chaperone . The study include patient early late-onset Pompe disease .</detailed_description>
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<mesh_term>Glycogen Storage Disease</mesh_term>
	<criteria>Male female age Confirmed diagnosis Pompe disease ( early lateonset ) Clinically stable Written inform consent subject legal representative Other significant disease otherwise unsuitable study , determine investigator</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>